112 related articles for article (PubMed ID: 1463974)
21. Retinol supplementation and mesothelioma incidence in workers earlier exposed to blue asbestos (Crocidolite) at Wittenoom, Western Australia.
Alfonso HS; Reid A; de Klerk NH; Olsen N; Mina R; Ambrosini GL; Beilby J; Berry G; Musk BA
Eur J Cancer Prev; 2010 Sep; 19(5):355-9. PubMed ID: 20571403
[TBL] [Abstract][Full Text] [Related]
22. Role of occupational asbestos exposure in Hungarian lung cancer patients.
Mándi A; Posgay M; Vadász P; Major K; Rödelsperger K; Tossavainen A; Ungváry G; Woitowitz HJ; Galambos E; Németh L; Soltész I; Egerváry M; Böszörményi Nagy G
Int Arch Occup Environ Health; 2000 Nov; 73(8):555-60. PubMed ID: 11100950
[TBL] [Abstract][Full Text] [Related]
23. [Asbestos-related occupational cancers].
Ameille J; Ruffié P; Bergeret A
Rev Prat; 2004 Oct; 54(15):1649-59. PubMed ID: 15605578
[TBL] [Abstract][Full Text] [Related]
24. Tumor markers kinetic in malignant lung neoplasms.
Cristofori R; Aimo G; Mengozzi G; Oliaro A; Revello F; Rapellino M
J Cardiovasc Surg (Torino); 1999 Apr; 40(2):299-305. PubMed ID: 10350122
[TBL] [Abstract][Full Text] [Related]
25. Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies.
Fuhrman C; Duche JC; Chouaid C; Abd Alsamad I; Atassi K; Monnet I; Tillement JP; Housset B
Clin Biochem; 2000 Jul; 33(5):405-10. PubMed ID: 11018693
[TBL] [Abstract][Full Text] [Related]
26. Serum tissue polypeptide antigen (TPA) modifications after fiberoptic bronchoscopy.
Rapellino M; Pecchio F; Ruffini E; Cianci R; Pinach S
Int J Biol Markers; 1992; 7(4):271-2. PubMed ID: 1491189
[No Abstract] [Full Text] [Related]
27. The antioxidants vitamins A and E and selenium do not reduce the incidence of asbestos-induced disease in a mouse model of mesothelioma.
Robinson C; Woo S; Walsh A; Nowak AK; Lake RA
Nutr Cancer; 2012; 64(2):315-22. PubMed ID: 22292488
[TBL] [Abstract][Full Text] [Related]
28. Fibre type and concentration in the lungs of workers in an asbestos cement factory.
Gylseth B; Mowé G; Wannag A
Br J Ind Med; 1983 Nov; 40(4):375-9. PubMed ID: 6313034
[TBL] [Abstract][Full Text] [Related]
29. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.
Pass HI; Lott D; Lonardo F; Harbut M; Liu Z; Tang N; Carbone M; Webb C; Wali A
N Engl J Med; 2005 Oct; 353(15):1564-73. PubMed ID: 16221779
[TBL] [Abstract][Full Text] [Related]
30. The role of intervention studies in ascertaining the contribution of dietary factors in lung cancer. The Seattle chemoprevention trial of retinoids in asbestos-exposed workers.
Omenn GS; Goodman GE; Kleinman GD; Rosenstock L; Barnhart S; Feigl P; Thomas DB; Kalman D; Lund B; Prentice RL
Ann N Y Acad Sci; 1988; 534():575-83. PubMed ID: 3389681
[No Abstract] [Full Text] [Related]
31. Identification of a mesothelioma phenotype.
Ohar JA; Ampleford EJ; Howard SE; Sterling DA
Respir Med; 2007 Mar; 101(3):503-9. PubMed ID: 16919927
[TBL] [Abstract][Full Text] [Related]
32. Mesothelin-family proteins and diagnosis of mesothelioma.
Robinson BW; Creaney J; Lake R; Nowak A; Musk AW; de Klerk N; Winzell P; Hellstrom KE; Hellstrom I
Lancet; 2003 Nov; 362(9396):1612-6. PubMed ID: 14630441
[TBL] [Abstract][Full Text] [Related]
33. Plasma vitamin concentrations and incidence of mesothelioma and lung cancer in individuals exposed to crocidolite at Wittenoom, Western Australia.
Alfonso HS; Fritschi L; de Klerk NH; Ambrosini GL; Beilby J; Olsen N; Musk AW
Eur J Cancer Prev; 2006 Aug; 15(4):290-4. PubMed ID: 16835500
[TBL] [Abstract][Full Text] [Related]
34. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.
Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A
Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637
[TBL] [Abstract][Full Text] [Related]
35. Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene.
de Klerk NH; Musk AW; Ambrosini GL; Eccles JL; Hansen J; Olsen N; Watts VL; Lund HG; Pang SC; Beilby J; Hobbs MS
Int J Cancer; 1998 Jan; 75(3):362-7. PubMed ID: 9455794
[TBL] [Abstract][Full Text] [Related]
36. Recent data on cancer due to asbestos in the U.S.A. and Denmark.
Nicholson WJ; Raffn E
Med Lav; 1995; 86(5):393-410. PubMed ID: 8684290
[TBL] [Abstract][Full Text] [Related]
37. Baseline serum β-carotene concentration and mortality among long-term asbestos-exposed insulators.
Hashim D; Gaughan D; Boffetta P; Lucchini RG
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):555-60. PubMed ID: 25542826
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R
Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
[TBL] [Abstract][Full Text] [Related]
39. Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma.
Creaney J; Olsen NJ; Brims F; Dick IM; Musk AW; de Klerk NH; Skates SJ; Robinson BW
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2238-46. PubMed ID: 20651076
[TBL] [Abstract][Full Text] [Related]
40. Validity of mesothelin in occupational medicine practice.
Smolková P; Nakládalová M; Zapletalová J; Jakubec P; Vildová H; Kolek V; Petřek M; Nakládal Z
Int J Occup Med Environ Health; 2016; 29(3):395-404. PubMed ID: 26988879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]